+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Isosorbide Mononitrate"

Isosorbide - Global Strategic Business Report - Product Thumbnail Image

Isosorbide - Global Strategic Business Report

  • Report
  • August 2025
  • 196 Pages
  • Global
From
Isosorbide Mononitrate Tablet Global Market Report 2025 - Product Thumbnail Image

Isosorbide Mononitrate Tablet Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Ischemic Heart Disease (IHD) Drugs Market Report 2025 - Product Thumbnail Image

Ischemic Heart Disease (IHD) Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Myocardial Infarction Market Report 2025 - Product Thumbnail Image

Myocardial Infarction Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Medications For Heart Failure Global Market Report 2025 - Product Thumbnail Image

Medications For Heart Failure Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

Isosorbide Mononitrate is a cardiovascular drug used to treat and prevent angina, or chest pain. It is a nitrate that works by relaxing and widening blood vessels, allowing more oxygen-rich blood to flow to the heart. It is available in both immediate-release and extended-release forms, and is usually taken twice daily. Common side effects include headache, dizziness, and nausea. Isosorbide Mononitrate is a generic drug, and is available in many countries around the world. It is also available in combination with other drugs, such as aspirin and hydrochlorothiazide. It is often used in combination with other drugs to treat high blood pressure and heart failure. The Isosorbide Mononitrate market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Mylan, Teva Pharmaceuticals, Sandoz, and Pfizer. Show Less Read more